Brain Targeted RNAi Therapy for Alzheimer's Disease

StatusActive
Effective start/end date22/08/1831/08/20

Funding

  • Alzheimer's Disease Program: $211,970.00

Keywords

  • Aging & Alzheimers, Nanotechnology, Translational